Feb 5 (Reuters) - Medical equipment maker Steris STE.N lowered its annual profit forecast on Wednesday, citing the impact of a stronger dollar.
The Dublin-based company lowered its fiscal 2025 adjusted profit to the range of $9.05 to $9.15 per share, from a prior forecast of $9.05 to $9.25 per share.
"This outlook does not reflect any potential impact from new tariffs." the company said.
Manufacturers of medical devices have been benefiting from elevated demand for elective surgical procedures in the United States, especially among older adults.
Steris, which produces surgical instruments, reported quarterly revenue of $1.37 billion, slightly below analysts' estimates of $1.38 billion, according to data compiled by LSEG.
The healthcare segment of the company, which provides sterilization products to healthcare providers, saw its quarterly revenue rise 7% in the third quarter ended December 31, to $976.0 million.
On an adjusted basis, the company reported a profit of $2.32 per share, which was in line with analysts' expectations.
(Reporting by Christy Santhosh in Bengaluru; Editing by Mohammed Safi Shamsi)
((Christy.Santhosh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。